The Medical Polyoxymethylene Market Is Estimated To Witness High Growth Owing To Trends In Medical Device Miniaturization
The Medical Polyoxymethylene Market Is Estimated To Witness High Growth Owing To Trends In Medical Device Miniaturization
The Medical Polyoxymethylene Market is estimated to be valued at US$ 206.53 Mn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

The Medical Polyoxymethylene Market is estimated to be valued at US$ 206.53 Mn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:


Medical polyoxymethylene or polyacetal, also known as polyformaldehyde or pox, is a thermoplastic used in fabrication of various medical device components and applications. Its self-lubricating properties and dimensional stability make it suitable for production of parts requiring wear and impact resistance like surgical instruments, dental prosthetics and tubing’s. Its biocompatibility and ease in sterilization also promotes its widespread use in medical industry.


Market key trends:


Miniaturization of medical devices is one of the key trend spurring growth of Medical Polyoxymethylene market. Advancements in microelectronics and micro-manufacturing technologies has enabled design and fabrication of miniature medical tools. Polyoxymethylene allows precise molding of miniaturized components for applications like minimally invasive surgical tools, diagnostic kits, implantable devices and catheters owing to its high strength, stiffness and dimensional stability properties. Its autoclavability at high temperatures also supports sterilization of miniature parts. Growing chronic diseases and aging population is augmenting demand for minimally invasive procedures which in turn is propelling growth of Medical Polyoxymethylene market for miniaturized medical device components.


Porter’s Analysis


Threat of new entrants: The threat of new entrants in the medical polyoxymethylene market is moderate. High capital requirements and stringent regulatory norms pose a barrier for new players.

Bargaining power of buyers: The bargaining power of buyers in the medical polyoxymethylene market is high due to the presence of many large scale hospitals and medical device manufacturers. Buyers can negotiate on price and demand discounts for bulk purchases.

Bargaining power of suppliers: The bargaining power of suppliers is moderate. The key raw materials are abundantly available however ongoing innovations and research require collaboration with suppliers.

Threat of new substitutes: Substitutes like polycarbonate and nylon pose a low threat as polyoxymethylene has unmatched mechanical strength, durability and heat resistance required for medical applications.

Competitive rivalry: The market has few international players with others focusing on niche segments intensifying competition.


SWOT Analysis


Strengths: Superior mechanical properties, biocompatibility, heat resistance and versatility making it suitable for medical devices. Established production facilities of key players.

Weaknesses: High raw material and production costs compared to substitutes. Vulnerable to price fluctuations in raw materials market.

Opportunities: Increasing global disease burden and focus on healthcare access driving demand for affordable medical devices. Potential in 3D printing of implants and personalized devices.

Threats: Stringent regulations. Vulnerable to slower economic growth affecting discretionary healthcare spending. Substitution threat from emerging biomaterials.


Key Takeaways


The Global Medical Polyoxymethylene Market Growth is expected to witness high, exhibiting CAGR of 3.3% over the forecast period, due to increasing demand for affordable healthcare amid rising disease burden worldwide.

Regionally, Asia Pacific dominates the global market and is expected to grow at the fastest pace during the forecast period. This is attributed to rising health expenditures, availability of raw materials and labor, and presence of key players in countries like China and India engaged in manufacturing medical devices at competitive costs.

Key players operating in the medical polyoxymethylene market are BASF SE, Celanese Corporation, Daicel Corporation (Polyplastics Co. Ltd), DuPont de Nemours Inc., Ensinger, Korea Engineering Plastics Co. Ltd, Mitsubishi Chemical Corporation, Westlake Plastics Company, and Yuntianhua Group Co. Ltd. These players are focusing on product innovation, capacity expansion and mergers & acquisitions to strengthen their market position.

 

Read More - https://www.newsanalyticspro.com/medical-polyoxymethylene-market-growth-and-analysis-share-demand-and-size-forecast/

What's your reaction?

Comments

https://www.timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations